The Board of SGH Shuffles Up

Shuffling in Slater

Shuffling in Slater and Gordon’s Board

On September 26, 2018, Slater and Gordon (ASX: SGH) came out with the press release which throws light on the changes which have been done in the board of the company. As per the press release issued, Hayden Stephens would no longer be the director of the company. John Somerville, the company’s chief executive officer or CEO would be taking the charge of Managing Director or MD as well. The company’s secretary or CS and General Counsel named Michael Neilson would now known as SGH’s Executive Director, Legal and Governance.

James MacKenzie, the company’s chairman appreciated the roles and responsibilities of the outgoing Director named Hayden Stephens. He has served the company for the tenure of 25 years and was dealing with a lot of legal cases which were faced by the company.

At the time of writing, the stock price of Slater and Gordon was A$2.66 which implies that the stock rose 0.38% intraday. As of September 26, 2018, the company has market capitalization or cap of $184.25 million.

A Quick View of Slater & Gordon’s FY 2018 Results:

Slater and Gordon’s (ASX:SGH) FY 2018 financial results saw a non-recurring benefit from the company’s decision to dispose-off of the UK business in late 2017. However, this decision represents its recapitalization strategy. The company posted net loss post tax from the ongoing operations on the back of the expenses incurred with regard to the transformation program and its divestments activities. However, as a result of the company’s transformation program, it is expected to witness an improvement in the top line as well as bottom line numbers. [optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

The expected robust performance of the company is underpinned by the significant capital structure, improvement in the service offering as well as simpler operating model. These positive changes have been made possible only because of the transformation program. The company’s revenues as well as other income amounted to $159.3 million in FY 2018 which implies the YoY decline stemming from the size reduction. In FY 2017, the figure clocked in at $181.5 million. These numbers have been generated with the help of continuing operations. The company’s top management has an optimistic outlook on the changes that have been incorporated by it. The company is on the path to achieve the long-term growth. The company’s core focus area happens to be improving the core services which they are rendering. It also plans to move on the path of innovation.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report